Category Archives: Investment

Q2 2016 San Diego Venture Capital Funding Dashboard

0 CommentsBy

VC Funding Dashboard- SD Q2 2016San Diego companies reported 19 venture capital deals totaling $350.5 million in the second quarter. The funding total was 26.7 percent higher than the 10-year average. The largest local cluster of industries, life sciences/medical, raised $257.3 million in the second quarter.

For more information, contact:
Joshua Brant, Senior Research… Read More

U.S. Investment Outlook Report | 2Q 2016

0 CommentsBy

USInvOut

Nine months of bumpiness in the financial markets, driven largely by the slowdown in China, oil pricing and, most recently, the Brexit, continued in Q2, but is showing signs of calming. While this has impacted deal flow in 2016 and uncertainty remains around the upcoming U.S. election, real estate capital markets are starting… Read More

Brexit’s potential implications for the U.S. economy and property markets

0 CommentsBy

flags

The surprise result of the UK’s exit vote has created significant political uncertainty and financial volatility. However: We believe the economic and property market impact for the United States will be relatively small. 

The risk of a renewed financial market crisis is the big concern, but the financial markets have already started to come back after a rout the first two days following the… Read More

Evolving healthcare sector rewards CRE investors

0 CommentsBy

by Chris Ross, Vice President | Healthcare Practice Group

entrance of medical office

Healthcare is one of the most steadily growing and predictable sectors of the economy, and healthcare real estate is attracting high levels of interest from investors of all types – from local private capital to massive healthcare REITs and everything in between. Here’s… Read More

Leasing activity within the San Diego life sciences cluster hit record levels in 2014 [REPORT]

0 CommentsBy

 

Major lab supply: Clusters of established lab stock with long-time industry presence

San Diego saw $43.8 billion in M&A transactions from 2011 through 2014. Large pharmaceutical companies are purchasing biotech firms to fill their R&D pipelines, rather than conduct R&D internally. San Diego has a strong R&D market due in… Read More

Coastal Cities Dominate JLL’s 2015 List of Top U.S. Life Sciences Clusters [REPORT]

0 CommentsBy
JLL’s annual Life Sciences Outlook Report reveals growth in pharmaceutical and biotech industries despite rising labor and real estate costs

U.S. biopharmaceutical innovation is thriving, with areas like Boston, Raleigh-Durham and San Diego dominating U.S. life sciences activity. However, a scarcity of laboratory space is pushing biopharmaceutical companies to seek locations in suburban markets where space is available or can be constructed, while still providing proximity to talent and resources.

These trends, along with… Read More

The impact of foreign investment on the U.S. Skyline

0 CommentsBy


The skylines of the U.S.’ great gateway cities have always been a welcome sight to those looking to make their mark in the land of opportunity.

And although they’ve evolved over the years, these skylines still have a special draw for investors looking for a good home for their money.

Foreign investors now represent two of every five dollars invested in U.S. Skyline property, according to JLL’s recently released 2015 Digital Skyline. Those cross-border dollars… Read More

JLL’s Lynn LaChapelle Named One of San Diego Metro’s Women Who Impact 2015

0 CommentsBy

Lynn LaChapelleIn the May issue of SD Metro, JLL’s Lynn LaChapelle is featured as one of 20 Women Who Impact in San Diego, which is a group of outstanding professional who have made a name for themselves in their careers and are making significant contributions to our community.

Many of San Diego’s major real estate deals include Lynn LaChapelle. As a Managing Director for… Read More